625 / 881
German Cancer Consortium (DKTK)
DOSE CONSTRAINTS:
BRACHIAL PLEXUS
• 37 apical lesions treated to a median total dose of 57
Gy,
• median maximum brachial plexus dose of patients
developing brachial plexopathy: 30 Gy (18-82)
(
EqD2 not applicable
).
• 7/37 apical lesions developed grade 2-4 plexopathy.
• Brachial plexus maximum dose should be kept <26 Gy
in 3 (
EqD2: 59.9 Gy)
or 4 (
EqD2: 49.4 Gy
) fractions.